NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Cerebellar Mutism Syndrome Study

RecruitingN/A

Sponsor: Rigshospitalet, Denmark

Conditions: Infratentorial Neoplasms, Mutism

Countries: Austria, Belgium, Czechia, Denmark, Finland, Germany, Hungary, Italy

The purpose of this study is to determine why up to 25% of the pediatric patients who have surgery for a tumor in the posterior fossa develops the Cerebellar Mutism Syndrome (CMS). Furthermore the purpose is to explore the clinical course and the best treatment of the syndrome.

Eligibility overview

Sex: ALL

Age: — to 18 Years

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

* Age \< 18 years at the date of first imaging showing this tumour
* Tumour in the cerebellum/4th ventricle/brainstem with intention to treat with surgical resection or open biopsy. Second and further surgeries are also included.
* Informed consent from custodial parent(s)

Exclusion Criteria:

* None

Locations (32)

Vienna, Austria
Leuven, Belgium
Prague, Czechia
Aalborg, Denmark
Aarhus, Denmark
Copenhagen, Denmark
Odense, Denmark
Helsinki, Finland
Kuopio, Finland
Oulu, Finland
Tampere, Finland
Turku, Finland
Leipzig, Germany
Tübingen, Germany
Budapest, Hungary
Rome, Rome, Italy
Kaunas, Lithuania
Nijmegen, Gelderland, Netherlands
Groningen, Netherlands
Utrecht, Netherlands
Bergen, Norway
Oslo, Norway
Tromsø, Norway
Trondheim, Norway
Barcelona, Spain
Gothenburg, Sweden
Linköping, Sweden
Skåne, Sweden
Stockholm, Sweden
Umeå, Sweden
+ 2 more on CT.gov